May 2009 news about us
Articles that mention MVI
Malaria vaccine tested in African clinical trial
May 30, 2009 –
Researchers have begun a major clinical trial in Africa of what could become the world's first vaccine against malaria, a disease that kills nearly a million people every year.
The Wall Street Journal
Un essai de vaccin contre le paludisme est lancé en Afrique
May 29, 2009 –
Un essai international à grande échelle avec un candidat vaccin contre le paludisme a démarré, mardi 26 mai à Bagamoyo (Tanzanie). Il évaluera chez 16 000 enfants et nourrissons l'efficacité du vaccin expérimental "RTS, S", mis au point par le laboratoire GlaxoSmithKline (GSK) Biologicals, avec lequel des résultats encourageants ont été obtenus (Le Monde du 10 décembre 2008).
Le Monde
Malaria vaccine enters phase III clinical trials
May 27, 2009 –
The world's most advanced malaria vaccine entered its final phase of pre-approval testing yesterday in Bagamoyo, Tanzania, raising hopes that the drug could be licensed for widespread use by 2012.
Nature
Biotech non profits immune to recession — for now
May 8, 2009 – A local vaccine maker is doing the unthinkable in a recession. It’s hiring. And expanding its manufacturing quarters. And starting new clinical trials.
Washington Business Journal
Researchers advance toward effective malaria vaccine
May 7, 2009 – Malaria kills millions of people annually, many of them children. So far, the disease has defied scientists who have tried to create a vaccine against it. But now, there are several vaccines in different testing phases.
Voice of America
